Trademark: 97541157
Word
KEPZAVYQ
Status
Pending
Status Code
730
Status Date
Monday, March 4, 2024
Serial Number
97541157
Mark Type
4
Filing Date
Tuesday, August 9, 2022
Published for Opposition
Tuesday, July 11, 2023

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events
Jun 3, 2023
Approved For Pub - Principal Register
Aug 12, 2022
New Application Entered
Aug 15, 2022
New Application Office Supplied Data Entered
May 20, 2023
Assigned To Examiner
May 20, 2023
Examiners Amendment -Written
May 20, 2023
Examiners Amendment E-Mailed
May 20, 2023
Notification Of Examiners Amendment E-Mailed
May 20, 2023
Examiner's Amendment Entered
Jun 21, 2023
Notification Of Notice Of Publication E-Mailed
Jul 11, 2023
Published For Opposition
Jul 11, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 12, 2023
Teas Change Of Owner Address Received
Jul 12, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 12, 2023
Teas Change Of Correspondence Received
Sep 5, 2023
Noa E-Mailed - Sou Required From Applicant
Mar 4, 2024
Sou Teas Extension Received
Mar 4, 2024
Sou Extension 1 Filed
Mar 5, 2024
Notice Of Approval Of Extension Request E-Mailed
May 1, 2024
Teas Petition To Amend Basis Received
Mar 4, 2024
Sou Extension 1 Granted

Trademark Alertz updated from USPTO on 2030-01-24